WikiCitingRetracted

Oldest pages

Showing below up to 100 results in range #51 to #150.

View (previous 100 | next 100) (20 | 50 | 100 | 250 | 500)

  1. Post operative nausea and vomiting‏‎ (15:44, 6 August 2022)
  2. Amosetron compared with granisetron for the prevention of postoperative nausea and vomiting following general anesthesia for breast mass excision‏‎ (15:45, 6 August 2022)
  3. Effects of ondansetron and granisetron on postoperative nausea and vomiting in adult patients undergoing laparoscopic cholecystectomy a randomizedae‏‎ (15:45, 6 August 2022)
  4. ETACTED ATICLE Current prevention and treatment of postoperative nausea and vomiting with 5-hydroxytryptamine type 3 receptor antagonists a review‏‎ (15:45, 6 August 2022)
  5. Comparison of the efficacy of 2 mg versus 5 mg tropisetron in the management of post-operative nausea and vomiting‏‎ (15:45, 6 August 2022)
  6. Treatment of postoperative emetic symptoms with granisetron in women undergoing abdominal hysterectomy A randomized, double-blind, placebo-controlledae‏‎ (15:46, 6 August 2022)
  7. Current therapy for management of postoperative nausea and vomiting The 5-HT3 receptor antagonists‏‎ (15:46, 6 August 2022)
  8. Efficacy of generic granisetron vs Kytrila for PONV in major gynecological operations a randomized, double-blind clinical trial‏‎ (15:46, 6 August 2022)
  9. Granisetron and granisetron dexamethasone combination for prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy aae‏‎ (15:46, 6 August 2022)
  10. Anesthasie du patient ambulatoire‏‎ (15:47, 6 August 2022)
  11. Tiroidektomi cerrahisinde sevofluran, izofluran ve propofol ile total intravenaz anestezinin postoperatif bulanta ve kusma azerine etkileri‏‎ (15:47, 6 August 2022)
  12. Prophylaxis and therapy of postoperative nausea and vomiting‏‎ (15:47, 6 August 2022)
  13. Intravenous Granisetron, Ondansetron and Metoclopramide in the Prevention and Treatment of Post Operative Nausea and Vomiting after Laparoscopicae‏‎ (15:47, 6 August 2022)
  14. Comparative efficacy of ondansetron versus granisetron to prevent perioperative nausea and vomiting in patients undergoing gynaecological surgery under spinalae‏‎ (15:48, 6 August 2022)
  15. Comparison of ondansetron and granisetron for antiemetic prophylaxis in maxillofacial surgery patients receiving general anesthesia a prospectiveae‏‎ (15:48, 6 August 2022)
  16. Anestesia del paciente ambulatorio‏‎ (15:48, 6 August 2022)
  17. Postoperative abelkeit und ErbrechenaeInzidenz, Prophylaxe, Therapie‏‎ (15:48, 6 August 2022)
  18. Laparoskopik Jinekoloji Cerrahisinde Profilaktik 5-Hidroksitriptamin Tip 3 Antagonistlerinin Antiemetik Etkinliai‏‎ (15:49, 6 August 2022)
  19. A comparative study of ondansetron and granisetron in combination with dexamethasone-in prophylaxis for postoperative nausea and vomiting (PONV) inae‏‎ (15:49, 6 August 2022)
  20. Comparison of antiemetic activity of palonosetron with granisetron in postoperative nausea and vomiting after laparoscopic gynaecological surgeries‏‎ (15:49, 6 August 2022)
  21. Effect of temperature on diaphragmatic function‏‎ (15:49, 6 August 2022)
  22. Palonosetron and granisetron in postoperative nausea vomiting A randomized double-blind prospective study‏‎ (15:50, 6 August 2022)
  23. Comparison of Granisetron, Palonosetron and Ondansetron for Prevention of Postoperative Nausea and Vomiting in Gynaecological Surgery under Generalae‏‎ (15:50, 6 August 2022)
  24. A study of comparing single dose granisetron with combination of granisetron with dexamethasone in preventing postoperative nausea vomiting in laparoscopicae‏‎ (15:50, 6 August 2022)
  25. Comparison of antiemetic efficacy of palonosetron, ondansetron and granisetron in prevention of postoperative nausea and vomiting‏‎ (15:50, 6 August 2022)
  26. Esearch article A COMPAATIVE STUDY BETWEEN ONDANSETON AND GANISETON PEOPEATIVELY FO PEVENTION OF POSTOPEATIVEae‏‎ (15:51, 6 August 2022)
  27. Attenuation of Post-operative Nausea and Vomiting with Granisetron and amosetron after General Anesthesia‏‎ (15:51, 6 August 2022)
  28. Comparison of prophylactic granisetron and granisetron with dexamethasone in the prevention of post-operative nausea and vomiting in patientsae‏‎ (15:51, 6 August 2022)
  29. ESEACH ATICLE A COMPAATIVE STUDY OF ONDANSETON AND GANISETON IN COMBINATION WITH DEXAMETHASONE IN PEVENTION OFae‏‎ (15:51, 6 August 2022)
  30. Anestesia del paziente ambulatoriale‏‎ (15:52, 6 August 2022)
  31. Obesity genetics in mouse and human back and forth, and back again‏‎ (15:52, 6 August 2022)
  32. Central regulation of metabolism by protein tyrosine phosphatases‏‎ (15:52, 6 August 2022)
  33. Linking gut microbiota and inflammation to obesity and insulin resistance‏‎ (15:52, 6 August 2022)
  34. A homozygous mutation in the TUB gene associated with retinal dystrophy and obesity‏‎ (15:53, 6 August 2022)
  35. A novel role for protein tyrosine phosphatase 1B as a positive regulator of neuroinflammation‏‎ (15:53, 6 August 2022)
  36. IKKiu is key to induction of insulin resistance in the hypothalamus, and its inhibition reverses obesity‏‎ (15:53, 6 August 2022)
  37. Hypothalamic obesity in children pathophysiology to clinical management‏‎ (15:53, 6 August 2022)
  38. Tyrosine kinase inhibitors as novel drugs for the treatment of diabetes‏‎ (15:54, 6 August 2022)
  39. Ecent progress in the understanding of obesity contributions of genome-wide association studies‏‎ (15:54, 6 August 2022)
  40. Neuroprotective effects of protein tyrosine phosphatase 1B inhibition against E stress-induced toxicity‏‎ (15:54, 6 August 2022)
  41. A PGC1-i-dependent myokine that drives brown-fat-like development of white fat and thermogenesis‏‎ (15:55, 6 August 2022)
  42. The role of lipid droplets in metabolic disease in rodents and humans‏‎ (15:55, 6 August 2022)
  43. C/EBPi controls exercise-induced cardiac growth and protects against pathological cardiac remodeling‏‎ (15:55, 6 August 2022)
  44. Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes‏‎ (15:56, 6 August 2022)
  45. Ectopic lipid storage and insulin resistance a harmful relationship‏‎ (15:56, 6 August 2022)
  46. Endocytosis, recycling, and regulated exocytosis of glucose transporter 4‏‎ (15:56, 6 August 2022)
  47. E-evaluating lipotoxic triggers in skeletal muscle relating intramyocellular lipid metabolism to insulin sensitivity‏‎ (15:56, 6 August 2022)
  48. High-fat diet-mediated lipotoxicity and insulin resistance is related to impaired lipase expression in mouse skeletal muscle‏‎ (15:57, 6 August 2022)
  49. Hyperglycaemia normalises insulin action on glucose metabolism but not the impaired activation of AKT and glycogen synthase in the skeletal muscle ofae‏‎ (15:57, 6 August 2022)
  50. Unraveling the roles of PLIN5 linking cell biology to physiology‏‎ (15:57, 6 August 2022)
  51. Insulin resistance and atherosclerosis‏‎ (15:57, 6 August 2022)
  52. Growth hormone and metabolism‏‎ (15:58, 6 August 2022)
  53. Ole of insulin resistance and hyperglycemia in the development of atherosclerosis‏‎ (15:58, 6 August 2022)
  54. Somatostatin-a regulatory modulator connecting nutrient entry and metabolism‏‎ (15:58, 6 August 2022)
  55. The role of insulin resistance in the pathogenesis of atherosclerotic cardiovascular disease an updated review‏‎ (15:58, 6 August 2022)
  56. The effects of cyproterone acetate and ethinyl oestradiol on carbohydrate metabolism‏‎ (15:59, 6 August 2022)
  57. A critical interpretation of experiments of binding of peptide hormone to specific receptors by computer modelling‏‎ (15:59, 6 August 2022)
  58. Genetic influences on glucose neurotoxicity, aging, and diabetes a possible role for glucose hysteresis‏‎ (15:59, 6 August 2022)
  59. Insulin-induced receptor regulation in cultured Zajdela rat hepatoma cells and relationship to the stimulation of glycogen synthesis.‏‎ (15:59, 6 August 2022)
  60. Acute regulation of human lymphocyte insulin receptors. Analysis by the glucose clamp.‏‎ (16:00, 6 August 2022)
  61. An essential role for fibronectin extra type III domain A in pulmonary fibrosis‏‎ (16:00, 6 August 2022)
  62. Expression and mutation analysis of the discoidin domain receptors 1 and 2 in non-small cell lung carcinoma‏‎ (16:00, 6 August 2022)
  63. Epithelialaemesenchymal interactions in pulmonary fibrosis‏‎ (16:01, 6 August 2022)
  64. Mapping of DD1 distribution and oligomerization on the cell surface by FET microscopy‏‎ (16:01, 6 August 2022)
  65. IGF2 overaeexpression in solitary fibrous tumours is independent of anatomical location and is related to loss of imprinting‏‎ (16:01, 6 August 2022)
  66. Interaction of discoidin domain receptor 1 with collagen type 1‏‎ (16:01, 6 August 2022)
  67. Fibrosis, chronic inflammation and new pathways for drug discovery‏‎ (16:02, 6 August 2022)
  68. Increased serum high mobility group boxae1 level in ChurgaeStrauss syndrome THIS ATICLE HAS BEEN ETACTED‏‎ (16:02, 6 August 2022)
  69. Hepatocyte growth factor is an attractive target for the treatment of pulmonary fibrosis‏‎ (16:02, 6 August 2022)
  70. Experimental models for the study of pulmonary fibrosis current usefulness and future promise‏‎ (16:02, 6 August 2022)
  71. Factorial design analysis of reduction of simulated iron ore sinter reduced with CO gas at 1000ae1100a C‏‎ (16:03, 6 August 2022)
  72. Simulation of austenitic stainless steel oxidation containing nitrogen at temperature range 500 Cae800 C‏‎ (16:03, 6 August 2022)
  73. Physicochemical processing of low grade ferruginous manganese ores‏‎ (16:03, 6 August 2022)
  74. Preliminary Study Of Processing Manganese Ore From Pringsewu District Of Lampung Province‏‎ (16:03, 6 August 2022)
  75. Analysis of the reduction yield of synthetic iron oxide sinter reduced by H‏‎ (16:04, 6 August 2022)
  76. Laser Welding of Coated Press-hardened Steel 22MnB5‏‎ (16:04, 6 August 2022)
  77. Effect of Pulsed Current Gas Tungsten Arc Process on the Dissimilar Weldments between Nickel-based Superalloy/Austenitic Stainless Steel‏‎ (16:04, 6 August 2022)
  78. Evidence-based management of postoperative nausea and vomiting a review‏‎ (16:04, 6 August 2022)
  79. Small-dose dexamethasone reduces nausea and vomiting after laparoscopic cholecystectomy a comparison of tropisetron with saline‏‎ (16:05, 6 August 2022)
  80. A randomized comparison of a multimodal management strategy versus combination antiemetics for the prevention of postoperative nausea and vomiting‏‎ (16:05, 6 August 2022)
  81. Amosetron, a 5-HT3 receptor antagonist for the control of nausea and vomiting‏‎ (16:05, 6 August 2022)
  82. The utility of antiemetics in the prevention and treatment of postoperative nausea and vomiting in patients scheduled for laparoscopic cholecystectomy‏‎ (16:05, 6 August 2022)
  83. Comparison of ramosetron with ondansetron for prevention of postoperative nausea and vomiting in patients undergoing gynaecological surgery‏‎ (16:06, 6 August 2022)
  84. A randomized, double-blind, multicenter trial comparing transdermal scopolamine plus ondansetron to ondansetron alone for the prevention of postoperative nauseaae‏‎ (16:06, 6 August 2022)
  85. Amosetron versus ondansetron for the prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy‏‎ (16:06, 6 August 2022)
  86. Anaesthetic considerations for laparoscopic cholecystectomy‏‎ (16:06, 6 August 2022)
  87. Postoperative nausea and vomiting prevention and therapy‏‎ (16:07, 6 August 2022)
  88. Diagnostic Challenge‏‎ (16:07, 6 August 2022)
  89. Bone marrow stem cell applied in the canine veterinary clinics‏‎ (16:07, 6 August 2022)
  90. Heterogeneous Photocatalytic Discoloration/Degradation of hodamine B with H2O2 and Spinel Copper Ferrite Magnetic Nanoparticles‏‎ (16:07, 6 August 2022)
  91. Kinetics of Ti02 Photocatalytic Decomposition‏‎ (16:08, 6 August 2022)
  92. Comparative efficacy and safety of ondansetron, droperidol, and metoclopramide for preventing postoperative nausea and vomiting a meta-analysis‏‎ (16:08, 6 August 2022)
  93. 5-HT3 receptor antagonistsvs traditional agents for the prophylaxis of postoperative nausea and vomiting‏‎ (16:08, 6 August 2022)
  94. Nausea, vomiting, and retching complex problems in palliative care‏‎ (16:09, 6 August 2022)
  95. Dimenhydrinate and metoclopramide alone or in combination for prophylaxis of PONV‏‎ (16:09, 6 August 2022)
  96. Systemic metoclopramide to prevent postoperative nausea and vomiting a meta-analysis without Fujiis studies‏‎ (16:10, 6 August 2022)
  97. A comparative analysis of isopropyl alcohol and ondansetron in the treatment of postoperative nausea and vomiting from the hospital setting to the home‏‎ (16:10, 6 August 2022)
  98. Template Polymerization of Aniline in Presence of Poly (acrylamide-co-maleic acid) for Preparation of Conductive Polymers‏‎ (16:11, 6 August 2022)
  99. High-frequency magnetic properties of soft magnetic cores based on nanocrystalline alloy powder prepared by thermal oxidation‏‎ (16:11, 6 August 2022)
  100. High frequency magnetic properties of Feaebased nanocrystalline alloy powder cores‏‎ (16:11, 6 August 2022)

View (previous 100 | next 100) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://wikicitingretracted.org/index.php?title=Special:AncientPages"